International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study

• Váldodahkkit: Fanny Ofek (Dahkki), Dana Barchel (Dahkki), Nofar Perets (Dahkki), Tomer Ziv-Baran (Dahkki), Ahmad Mahajna (Dahkki), Talia Filipovich-Rimon (Dahkki), Osnat Garach-Jehoshua (Dahkki), Maya Berlin (Dahkki), Matitiahu Berkovitch (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2019-10-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Introduction: In patients treated with direct oral anti activated factor X (anti-FXa) anticoagulants such as apixaban and rivaroxaban, there are several emergency and non-emergency conditions in which anticoagulation activity should be measured. The validity of the common global clotting tests, prot...